Literature DB >> 9649206

Augmented levels of macrophage and Th1 cell-related cytokine mRNA in submandibular glands of MRL/lpr mice with autoimmune sialoadenitis.

W Mustafa1, J Zhu, G Deng, A Diab, H Link, L Frithiof, B Klinge.   

Abstract

MRL/Mp-lpr/lpr (MRL/lpr) mice spontaneously develop destructive inflammation of the salivary and lachrymal glands resembling Sjögren's syndrome (SS), representing an animal model to study this disease. We used in situ hybridization with synthetic radiolabelled oligonucleotide probes to examine expression of mRNA encoding pro- and anti-inflammatory cytokines in submandibular glands of 2, 3, 4 and 5-month-old MRL/lpr mice. Phenotypic composition of submandibular gland infiltrates was evaluated by immunohistochemistry. Cells expressing tumour necrosis factor-alpha (TNF-alpha), IL-1beta, IL-6 and IL-12 mRNA were strongly up-regulated at about the time of onset of sialoadenitis, suggesting a role of these cytokines in development of the disease. Interferon-gamma (IFN-gamma) and cytolysin mRNA-expressing cells were gradually up-regulated over the disease course up to 5 months of age, the time when sialoadenitis is at its height, favouring a role of these cytokines in progression of the disease as well. Low levels of IL-10 and transforming growth factor-beta (TGF-beta) mRNA-expressing cells were observed at 2, 3 and 4 months of age, and were almost undetectable at 5 months. Maximum levels of CD4+, CD8+ and interdigitating/dendritic cells, as well as of MHC class II and MHC class I expression were seen at 3 months, with CD4+ outnumbering CD8+ cells. Maximum levels of macrophages were seen at 4 months of age. These data argue for a major role of the proinflammatory cytokines TNF-alpha, IL-1beta, IL-6, IL- 12, IFN-gamma and cytolysin in initiation and perpetuation of autoimmune sialoadenitis in MRL/lpr mice, probably in conjunction with an insufficiency of the anti-inflammatory cytokines TGF-beta and IL-10.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9649206      PMCID: PMC1905000          DOI: 10.1046/j.1365-2249.1998.00609.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  42 in total

1.  THE DEVELOPMENT OF MALIGNANT LYMPHOMA IN THE COURSE OF SJOEGREN'S SYNDROME.

Authors:  N TALAL; J J BUNIM
Journal:  Am J Med       Date:  1964-04       Impact factor: 4.965

Review 2.  SJOEGREN'S SYNDROME. A CLINICAL, PATHOLOGICAL, AND SEROLOGICAL STUDY OF SIXTY-TWO CASES.

Authors:  K J BLOCH; W W BUCHANAN; M J WOHL; J J BUNIM
Journal:  Medicine (Baltimore)       Date:  1965-05       Impact factor: 1.889

3.  Cytokine patterns in tuberculous and sarcoid granulomas: correlations with histopathologic features of the granulomatous response.

Authors:  A Bergeron; M Bonay; M Kambouchner; D Lecossier; M Riquet; P Soler; A Hance; A Tazi
Journal:  J Immunol       Date:  1997-09-15       Impact factor: 5.422

4.  Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis.

Authors:  R J Dolhain; A N van der Heiden; N T ter Haar; F C Breedveld; A M Miltenburg
Journal:  Arthritis Rheum       Date:  1996-12

5.  The spectrum of benign to malignant lymphoproliferation in Sjögren's syndrome.

Authors:  L G Anderson; N Talal
Journal:  Clin Exp Immunol       Date:  1972-02       Impact factor: 4.330

6.  In vivo role of IL-10 and IL-12 during development of Sjögren's syndrome in MRL/lpr mice.

Authors:  K Yanagi; N Haneji; H Hamano; M Takahashi; H Higashiyama; Y Hayashi
Journal:  Cell Immunol       Date:  1996-03-15       Impact factor: 4.868

Review 7.  The biological properties of interleukin-1.

Authors:  C A Dinarello
Journal:  Eur Cytokine Netw       Date:  1994 Nov-Dec       Impact factor: 2.737

8.  Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR).

Authors:  M Niessner; B A Volk
Journal:  Clin Exp Immunol       Date:  1995-09       Impact factor: 4.330

9.  Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.

Authors:  J Link
Journal:  Acta Neurol Scand Suppl       Date:  1994

10.  Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4.

Authors:  J A van Roon; J L van Roy; F H Gmelig-Meyling; F P Lafeber; J W Bijlsma
Journal:  Arthritis Rheum       Date:  1996-05
View more
  8 in total

1.  Calorie restriction decreases proinflammatory cytokines and polymeric Ig receptor expression in the submandibular glands of autoimmune prone (NZB x NZW)F1 mice.

Authors:  A R Muthukumar; C A Jolly; K Zaman; G Fernandes
Journal:  J Clin Immunol       Date:  2000-09       Impact factor: 8.317

2.  The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren's syndrome.

Authors:  D I Mitsias; A G Tzioufas; C Veiopoulou; E Zintzaras; I K Tassios; O Kogopoulou; H M Moutsopoulos; G Thyphronitis
Journal:  Clin Exp Immunol       Date:  2002-06       Impact factor: 4.330

Review 3.  Animal models of Sjögren's syndrome.

Authors:  Malin V Jonsson; Nicolas Delaleu; Roland Jonsson
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

Review 4.  Sjögren's syndrome: an old tale with a new twist.

Authors:  Byung Ha Lee; Mauro A Tudares; Cuong Q Nguyen
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2009-02-14       Impact factor: 4.291

Review 5.  Recent advances in autoimmune pancreatitis: concept, diagnosis, and pathogenesis.

Authors:  Kazuichi Okazaki; Kazushige Uchida; Toshiro Fukui
Journal:  J Gastroenterol       Date:  2008-07-04       Impact factor: 7.527

6.  Prevention of B220+ T cell expansion and prolongation of lifespan induced by Lactobacillus casei in MRL/lpr mice.

Authors:  A Mike; N Nagaoka; Y Tagami; M Miyashita; S Shimada; K Uchida; M Nanno; M Ohwaki
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

7.  miR-744-5p contributes to ocular inflammation in patients with primary Sjogrens Syndrome.

Authors:  Joan Ní Gabhann-Dromgoole; Conor C Murphy; Qistina Pilson; Siobhan Smith; Caroline A Jefferies
Journal:  Sci Rep       Date:  2020-05-04       Impact factor: 4.379

8.  Possible Involvement of Foxp3(+) Regulatory T Cells in the Development of Immune-Mediated Pancreatitis in MRL/Mp Mice Treated with Polyinosinic:Polycytidylic Acid.

Authors:  Masanori Koyabu; Kazushige Uchida; Yutaku Sakaguchi; Norimasa Fukata; Takeo Kusuda; Hideaki Miyoshi; Katsunori Yoshida; Kimi Sumimoto; Toshiyuki Mitsuyama; Toshiro Fukui; Akiyoshi Nishio; Kazuichi Okazaki
Journal:  Int J Rheumatol       Date:  2013-05-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.